We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Facility will become a state-of-the-art manufacturing and production site designed for late-stage and commercially-approved cell & gene therapy products by 2021.